Leading Healthcare and Life Science Executives Support UK Report Analysing the Realities of Investment in the Sector
London, UK, 19th January 2016 / Sciad Newswire / The UK’s Healthcare and Life Science sectors need capital and development expertise that will allow them to demonstrate key financial markets. Too often, myths and misconceptions about the challenges, benefits and potential of returns on investment in the UK’s healthcare sectors has deterred the financial community from supporting the sector. This report will shine a light on the real truths about investing in the sector
Supported by dozens of the UK’s leading healthcare and life science Executives, plus leading investors and sector stakeholders, the exclusive 100+ page report is intended to be a rallying cry to the wider financial community to support the UK’s Healthcare and Life Sciences sectors.
With contributions from Rt. Hon. George Freeman MP, Neil Woodford, Imperial Innovations, The London Stock Exchange, BIA and EY, plus case studies on 5 of the UK’s leading success stories, the report illustrates the fundamental truths about investing in the UK.
Dr Darrin M Disley, CEO of Horizon Discovery Group said ‘I am delighted to be a cornerstone supporter of this report. It represents a genuine opportunity to educate the investment community about the true potential of UK healthcare and life science companies. By illustrating the many success stories of UK life science companies through high quality analysis, coupled with sound bite stats, this initiative will go a long way toward debunking many of the myths and challenging preconceptions investors may have about investing in the sector. It is a catalyst to change investor attitudes and behaviour, and will become a handbook for anyone seeking to promote the industry. If you believe in the UK life science mission, I would urge you to support it.'
The report launch will feature in a prominent day 1 keynote session at the 2nd annual Biotech and Money London conference on February 2-3 at 155 Bishopsgate, Liverpool St. This 1hr session will feature the cornerstone players of the report as well as key industry stakeholders to discuss and debate the findings and highlights, plus debate the wider implications on the sector. There will also be an exclusive pre-launch Investor breakfast from 8-9am at the Biotech and Money London conference.
To find out more and to secure your own copy of the report when released please visit http://biotechandmoney.com/real-life-report/
About Biotech and Money
Biotech and Money is a growing influential community of senior life science decision makers. We are a catalyst for dialogue, debate and deal making to help lead growth in healthcare investment and the building of billion pound healthcare businesses. We are determined to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare. Visit www.biotechandmoney.com.
For media information please contact:
Chief Marketing Officer
Tel:+44 (0) 207 193 9664